By providing us with a phone number (including mobile) as your contact number, you expressly authorize us to contact you regarding your account for communication
GLP-1 Timeline: From Diabetes to Pediatric Weight Management 2005: First GLP-1 medications approved for Type 2 diabetes in adults 2014: FDA approves Saxenda (liraglutide) as the first GLP-1 for weight loss 2022: Wegovy approved for adolescents 12 and older 2023: American Academy of Pediatrics endorses GLP-1s for pediatric obesity 2025: FDA considering approval for children as young as 6 years old Though the FDA approved Saxenda as the first GLP-1 for weight loss back in 2014, it wasnt until the last few years that the popularity and availability of these medications for obesity have skyrocketed
Out of Stock Details IGF-1 LR3 (Insulin-like Growth Factor 1 Long Arg3) is a synthetic form of IGF-1, a protein that plays a key role in growth, development, and cellular repair
Q: Will losing weight on a GLP-1 drug fix my varicose veins
Detoxification of methylmercury by hydrogen sulfide-producing enzyme in Mammalian cells
A growing area of research suggests GLP-1/GIP therapies may reduce inflammation indirectly by: improving insulin resistance lowering visceral fat improving metabolic markers So while Zepbound is not prescribed specifically as an anti-inflammatory, some people may see improvements in inflammation-related markers as weight and metabolic health improve
![Article] Call to avoid buying fake versions of Ozempic and Mounjaro The South African Health Products Regulatory Authority (SAHPRA) has expressed concern at the increasing presence of counterfeit Glucagon-like Peptide (GLP-1) products](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1078755244257788)
